Seminars in Radiation Oncology
Volume 19, Issue 2 , Pages 133-139 , April 2009

Bone Marrow–Derived Stem Cells and Radiation Response

  • Joel S. Greenberger, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Joel S. Greenberger, MD. Department of Radiation Oncology, University of Pittsburgh, Cancer Institute, 200 Lothrop Street, Rm B346, Pittsburgh, PA 15213
    • ,
  • Michael Epperly, PhD

References 

  1. Irina K, Nadia R, Robert L. Derive and conquer: Sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov. 2008;7:131–140
  2. Henry K, Benjamin R. Stem cells in a new light. Nat Biotechnol. 2008;26:187–195
  3. Weksberg DC, Chambers SM, Boles NC, et al. CD150− side population cells represent a functionally distinct population of long-term hematopoietic stem cells. Blood. 2008;111:2444–2453
  4. Mauch P, Greenberger JS, Botnick LE, et al. Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. PNAS USA. 1980;77:2927–2930
  5. Till JE, McCulloch EA. Developmental Aspects of the Cell Cycle. New York, NY, Academic Press. 1971;297–313
  6. Sakakeeny MA, Greenberger JS. Granulopoiesis longevity in continuous bone marrow cultures and factor dependent cell line generation: Significant variation among 28 inbred mouse strains and outbred stocks. J Natl Cancer Inst. 1982;68:305–317
  7. Epperly MW, Cao S, Goff J, et al. Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3-/-mice. Exp Hematol. 2005;33:353–362
  8. FitzGerald TJ, Rothstein L, Kase K, Greenberger JS. Radiosensitivity of human bone marrow granulocyte-macrophage progenitor cells: Effect of dose rate on purified target cell populations. Radiat Res. 1986;107:205–215
  9. Samuel H. Stem-cell biology and cancer therapy: The more things change. J Clin Oncol. 2008;26:821–822
  10. Greenberger JS. Toxic effects on the hematopoietic microenvironment. Exp Hematol. 1991;19:1101–1109
  11. Parmar K, Mauch P, Vergilio J, et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. PNAS. 2007;104:5431–5436
  12. Eri M, Masahiro M, Shuro Y, et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood. 2008;111:2427–2435
  13. Epperly MW, Sikora CA, Defilippi S, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis (Resp Am J). Mol Cell Biol. 2003;29:213–224
  14. Greenberger JS, Anderson J, Berry LA, et al. Effects of irradiation of CBA/Ca mice on hematopoietic stem cells and stromal cells in long-term bone marrow cultures. Leukemia. 1996;10:514–527
  15. Greenberger JS, Epperly MW, Jahroudi N, et al. Role of bone marrow stromal cells in irradiation leukemogenesis. Acta Haematol. 1996;96:1–15
  16. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147
  17. Naparstek E, Pierce J, Metcalf D, et al. Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines. Blood. 1986;67:1395–1403
  18. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71–74
  19. Zhou S, Greenberger JS, Epperly MW, et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7(3):335–343
  20. Zhou S, Lechpammer S, Greenberger JS, et al. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires TGFβ/Smad3 signaling. J Biol Chem. 2005;280:22688–22696
  21. Engin F, Yao Z, Yang T, et al. Dimorphic effects of notch signaling in bone homeostasis. Nat Med. 2008;14:299–305
  22. Hilton MJ, Tu X, Wu X, et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med. 2008;14:306–312
  23. Goh K, Klemperer MR. In vivo leukemic transformation: Cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. Am J Hematol. 1977;2:283–290
  24. Harrison DE, Astle CM. Loss of stem cell repopulating ability upon transplantation: Effects of donor age, cell number, and transplantation procedure. J Exp Med. 1982;156:1767–1779
  25. Harrison DE, Astle CM, Delaittre JA. Loss of proliferative capacity immunohematopoietic stem cells caused by serial transplantation rather than aging. J Exp Med. 1978;147:1526–1531
  26. Anklesaria P, FitzGerald TJ, Kase K, et al. Improved hematopoiesis in anemic SI/SId mice by therapeutic transplantation of a hematopoietic microenvironment. Blood. 1989;74:1144–1152
  27. Quesenberry PJ, Colvin G, Abedi M. Perspective fundamental and clinical concepts on stem cell homing and engraftment: A journey to niches and beyond. Exp Hematol. 2005;33:9–19
  28. Werts ED, Gibson DP, Knapp SA, et al. Bone marrow fibroblasts circulate to replace damaged marrow sites. Radiat Res. 1980;81:20–30
  29. Anklesaria P, Kase KR, Glowacki J, et al. Engraftment of a clonal bone marrow stromal cell line in Vivo stimulates hematopoietic recovery from total body irradiation. PNAS USA. 1987;84:7681–7685
  30. Zipori D. The nature of stem cells: State rather than entity. Nat Rev. 2004;5:873–883
  31. Mothersill C, Seymour CB. Radiation-induced bystander effects—Implications for cancer. Nat Rev Cancer. 2004;4:158–164
  32. Zanjani ED, Flake AW, Almeida-Porada G, et al. Homing of human cells in the fetal sheep model: Modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood. 1999;94:2515–2522
  33. Roy V, Verfaillie CM. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol. 1999;27:302–312
  34. Ahmed F, Ings SJ, Pizzey AR, et al. Impaired bone marrow homing of cytokine-activated CD34+ cells in the Nod/SCID model. Blood. 2004;103:2074–2084
  35. Szilvassy SJ, Bass MJ, Van Zant G, et al. Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood. 1999;93:1557–1566
  36. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845–850
  37. Wysoczynski M, Reca R, Ratajczak J, et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood. 2005;105:40–50
  38. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425:836–840
  39. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:844–848
  40. Matsuzaki Y, Kinjo K, Mulligan RC, et al. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity. 2004;20:87–93
  41. Cancelas JA, Lee AW, Prabhakar R, et al. GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat Med. 2005;11:886–894
  42. Adams GB, Martin RP, Alley IR, et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol. 2007;25:238–242
  43. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 2000;287:1804–1808
  44. Christopherson KW, Hangoc G, Mantel CR, et al. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004;305:1000–1004
  45. Desponts C, Hazen AL, Paraiso KHT, et al. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood. 2006;107:4338–4342
  46. Lapidot T, Dar A, Kollet O. How do stem cells find their way home?. Blood. 2005;106:1901–1908
  47. Nilsson SK, Johnston HM, Whitty GA, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood. 2005;106:1232–1238
  48. Bently A, Kirby L, Anklesaria P, et al. Bone marrow stromal proteoglycan heterogeneity: Phenotypic variability between cell lines and the effects of glucocorticoid. J Cell Physiol. 1988;136:182–187
  49. Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25:977–988
  50. Anklesaria P, Teixido J, Laiho M, et al. Cell homing and proliferation mediated by membrane TGF-α binding to EGF receptor. PNAS USA. 1990;87:3289–3293
  51. Gorbunov NV, Pogue-Geile KL, Epperly MW, et al. Activation of the nitric oxide synthase 2 pathway in the response of bone marrow stromal cells to high doses of ionizing radiation. Radiat Res. 2000;154:73–86
  52. Pogue-Geile KL, Greenberger JS. The effect of the irradiated microenvironment on the expression and retrotransposition of intracisternal type A particles in hematopoietic cells. Exp Hematol. 2000;1:680–689
  53. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168–1170
  54. Epperly MW, Sikora C, Defilippi S, et al. Inhibits irradiation-induced apoptosis by stabilization of the mitochondrial membrane against the effects of SAP kinases p38 and Jnk1 translocation. Radiat Res. 2002;157:568–577
  55. Epperly MW, Goff JP, Sikora CA, et al. Bone marrow origin of cells with capacity for homing and differentiation to esophageal squamous epithelium. Radiat Res. 2004;162:233–240
  56. Krause D, Theise N, Collector M, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–377
  57. Greenberger JS, Epperly MW. Antioxidant therapeutic approaches toward amelioration of the pulmonary pathophysiological damaging effects of ionizing irradiation. Curr Respir Med Rev. 2007;3:29–37
  58. Niu Y, Epperly MW, Shen H, et al. Intraesophageal MnSOD-plasmid liposome enhances engraftment and self-renewal of bone marrow derived progenitors of esophageal squamous epithelium. Gene Ther. 2008;15:347–356
  59. Epperly MW, Smith T, Wang H, et al: Modulation of total body irradiation induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy. Radiat Res (in press)
  60. Rowland RE, Stehney AF, Lucas HF. Dose–response relationships for female radium dial workers. Radiat Res. 1978;76:368–383
  61. Court Brown WM, Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondilitis. Br J Med. 1965;2:1327–1332
  62. Preston DL, Kato K, Kopecky KI, et al. Studies of mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. Radiat Res. 1987;111:151–178
  63. Hoppe RT. Hodgkin's disease: Complications of therapy and excess mortality. Ann Oncol. 1997;8:115–118
  64. Tucker M, Coleman C, Cox R, et al. Risk of second cancer after treatment for Hodgkin's disease. N Engl J Med. 1988;318:76–81
  65. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004;306:1568–1571
  66. Thomas ED, Bryant JI, Buckner CD, et al. Leukemic transformation of engrafted human marrow. Transplant Proc. 1972;4:567–570
  67. Katz F, Reeves BR, Alexander S, et al. Leukemia arising in donor cells following allogeneic bone marrow transplantation for beta thalassaemia demonstrated by immunological, DNA, and molecular cytogenetic analysis. Br J Haematol. 1993;85:326–331
  68. Mouratidou M, Sotiropoulos D, Deremitzaki K, et al. Recurrence of acute leukemia in donor cells after bone marrow transplantation: Documentation by in situ DNA hybridization. Bone Marrow Transplant. 1993;12:77–80
  69. Cransac M, Boiron JM, Merel P, et al. Burkitt-type and lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation. 1993;56:120–123
  70. Lowsky R, Fyles G, Minden M, et al. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol. 1996;93:163–165
  71. Schubach WH, Hackman R, Neiman PE, et al. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood. 1982;60:180–187
  72. Marmont A, Frassoni F, Bacigalupo A, et al. Recurrence of Ph'-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N Engl J Med. 1984;310:903–906
  73. Cooley LD, Sears DA, Udden MM, et al. Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol. 2000;63:46–53
  74. Elfenbein GJ, Brogaonkar DS, Bias WB, et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood. 1978;52:627–636
  75. Fialkow PJ, Thomas ED, Bryant JI, et al. Leukaemic transformation of engrafted human marrow cells in Vivo. Lancet. 1971;1:251–255
  76. Palka G, Calabrese G, Di Girolamo G, et al. Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute nonlymphocyte and acute lymphoblastic leukemias. Cancer Genet Cytogenet. 1991;51:223–233
  77. Schmitz N, Johannson W, Schmidt G, et al. Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood. 1987;70:1099–1104
  78. Feig SA, Dreazen O, Simon M, et al. B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant. 1988;3:331–337
  79. Browne PV, Lawler M, Humphries P, et al. Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med. 1991;325:710–713
  80. McCann SR, Lawler M, Bacigalupo A. Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia. Leuk Lymph. 1993;10:419–425
  81. McCann SR, Lawler M, Humphries P, et al. Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia confirmation by microsatellite studies. Blood. 1992;79:2803–2805
  82. Sala-Torra O, Hanna C, Loken MR, et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:511–517

PII: S1053-4296(08)00082-9

doi: 10.1016/j.semradonc.2008.11.006

Seminars in Radiation Oncology
Volume 19, Issue 2 , Pages 133-139 , April 2009

Article Tools

* Image Usage & Resolution